We have been awarded the Frost & Sullivan’s 2023 Global Customer Value Leadership Award in the aseptic fill-and-finish market for the high performance for our customers. The award, presented annually by the international growth strategy consulting firm, focuses on both business and customer im…

– Bericht umfasst nun auch Scope 3-Emissionen
– Soziale Verantwortung für Mitarbeitende wichtiger Bestandteil der Nachhaltigkeitsaktivitäten
– Bis 2029 sollen Gesamtemissionen um zehn Prozent sinken

Vetter, eine weltweit führende Contract Development und Manufacturing Organisation (CDMO), führt seine Nach…

We have been recognized as Best Managed Company for the fourth time in a row – and now carrying gold status. The internationally renowned award is presented annually by Deloitte Private, Frankfurter Allgemeine Newspaper and the Federation of German Industries (BDI) to medium-sized and family-run c…

Vetter continues to drive the expansion of capacities and services for the provision of clinical trial materials: With the implementation of additional equipment for aseptic production and the expansion of storage capacities at the clinical site in Rankweil, Austria, we are responding to increasing…

Vetter earned the esteemed 2023 CDMO Leadership Awards in all six core categories – quality, expertise, reliability, capabilities, compatibility and service. In addition, we were awarded Champion Status for quality, expertise and compatibility – both recognitions for the second year in a row. In…

Vetter has recently become a participant of the UN Global Compact Network (UN GC). We are one of the pioneers in the industry regarding responsible, sustainable, and transparent business practices. To date, only 308 biopharmaceutical companies worldwide have signed the UN Global Compact. By joining…

With the increasing drug development for novel therapeutics, a growing number of pharmaceutical and biotech companies are seeking clinical manufacturing partners to help meet the demand for complex fill and finish solutions. And, while the stages of early drug development are challenging, we are com…

We achieved gold status in the renowned, independent EcoVadis sustainability ranking. With 72 points out of a maximum of 100, we significantly increased our score compared to the last evaluation and are now among the top five percent of all participating companies in the industry.

Sustainability play…

With a total investment of approx. 20 million euros, the new fully automated building provides storage space for materials with high-stock turnover rates such as packaging components and thus optimizing our logistical infrastructure. In addition, valuable capacity will be freed up in the existing wa…

With the realization of the first successful customer fills, we have reached another milestone at our new clinical manufacturing facility in Rankweil, Austria. Further batches are already planned, and more customer projects are in the business pipeline. In addition, the site is being expanded to opt…